A Renaissance for Oncolytic Adenoviruses?
A Renaissance for Oncolytic Adenoviruses?
About this item
Full title
Author / Creator
Publisher
Switzerland: MDPI AG
Journal title
Language
English
Formats
Publication information
Publisher
Switzerland: MDPI AG
Subjects
More information
Scope and Contents
Contents
In the 1990s, adenovirus became one of the first virus types to be genetically engineered to selectively destroy cancer cells. In the intervening years, the field of "oncolytic viruses" has slowly progressed and culminated in 2015 with the FDA approval of Talimogene laherparepvec, a genetically engineered herpesvirus, for the treatment of metastati...
Alternative Titles
Full title
A Renaissance for Oncolytic Adenoviruses?
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_22fad200541f49dcbcb69bd3f505a725
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_22fad200541f49dcbcb69bd3f505a725
Other Identifiers
ISSN
1999-4915
E-ISSN
1999-4915
DOI
10.3390/v15020358
